CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 46 filers reported holding CATALYST BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $41,000 | -85.5% | 62,729 | -79.7% | 0.00% | -100.0% |
Q4 2021 | $282,000 | +27.0% | 308,552 | +470.7% | 0.00% | – |
Q3 2021 | $222,000 | +33.7% | 54,069 | +41.3% | 0.00% | – |
Q2 2021 | $166,000 | -84.6% | 38,256 | -82.2% | 0.00% | -100.0% |
Q1 2021 | $1,081,000 | -47.1% | 214,566 | -33.8% | 0.00% | -50.0% |
Q4 2020 | $2,044,000 | +36.3% | 323,939 | -7.1% | 0.01% | +20.0% |
Q3 2020 | $1,500,000 | -19.8% | 348,780 | +9.4% | 0.01% | -44.4% |
Q2 2020 | $1,871,000 | +106.5% | 318,723 | +53.7% | 0.01% | +28.6% |
Q1 2020 | $906,000 | -41.6% | 207,305 | -9.0% | 0.01% | +40.0% |
Q4 2019 | $1,552,000 | +206.7% | 227,834 | +121.2% | 0.01% | +150.0% |
Q3 2019 | $506,000 | -36.2% | 102,986 | -4.3% | 0.00% | -33.3% |
Q2 2019 | $793,000 | -1.1% | 107,633 | +8.9% | 0.00% | 0.0% |
Q1 2019 | $802,000 | +76.3% | 98,863 | +71.3% | 0.00% | +50.0% |
Q4 2018 | $455,000 | -78.4% | 57,709 | -70.5% | 0.00% | -66.7% |
Q3 2018 | $2,111,000 | +254.2% | 195,849 | +283.3% | 0.01% | +200.0% |
Q2 2018 | $596,000 | +27.6% | 51,098 | +182.4% | 0.00% | 0.0% |
Q1 2018 | $467,000 | – | 18,093 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
BlackRock Inc. | 169,904 | $35,170 | 0.00% |
Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
Citadel Advisors | 5,700 | $1,180 | 0.00% |